SML1173

Lubiprostone

≥98% (HPLC)

• 동의어(들): (11a,15R)-11,15-Epoxy-16,16-difluoro-15-hydroxy-9-oxo-prostan-1-oic acid, Ru 0211, Spi 0211
• 실험식(Hill 표기법): C₂₀H₃₂F₂O₅
• CAS Number: 136790-76-6
• Molecular Weight: 390.46
• UNSPSC 코드: 12352200
• NACRES: NA.77

속성

• Quality Level: 100
• 분석: ≥98% (HPLC)
• 양식: powder
• 색상: white to beige
• solubility: DMSO: 20 mg/mL, clear
• 저장 온도: −20°C
• SMILES string: FC(F)([C@@]1(O[C@H]2[C@@H]([C@@H](C(=O)C2)CCCCCCC(=O)O)CC1)O)CCCC
• InChI: 1S/C20H32F2O5/c1-2-3-11-19(21,22)20(26)12-10-15-14(16(23)13-17(15)27-20)8-6-4-5-7-9-18(24)25/h14-15,17,26H,2-13H2,1H3,(H,24,25)/t14-,15+,17+,20+/m0/s1
• InChI key: WGFOBBZOWHGYQH-DKYLXPRQSA-N

설명

생화학적/생리학적 작용

Lubiprostone helps to enhance intestinal permeability in humans. Hence it may inhibit leaky gut syndrome.

Lubiprostone is a bicyclic fatty acid that activates ClC-2 and CFTR chloride channels.

Lubiprostone is a bicyclic fatty acid that activates ClC-2 and CFTR chloride channels. Some reports suggest that lubiprostone opens CFTR or both CFTR and ClC-2 through interactions with the prostaglandin receptor EP4. Lubiprostone is used clinically to treat idiopathic chronic constipation and irritible bowel syndrome.

안전성 정보

• 픽토그램: GHS07
• 신호어: Warning
• 유해 및 위험 성명서: H315,H319,H335
• 예방조치 성명서: P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338
• Hazard Classifications: Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
• 표적 기관: Respiratory system
• Storage Class Code: 11 - Combustible Solids
• WGK: WGK 3
• Flash Point (°F): Not applicable
• Flash Point (°C): Not applicable